A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
RemeGen Co., Ltd.
Pfizer
Pfizer
Pfizer
Leaf Vertical Inc.
Sirtex Medical
Eli Lilly and Company
AGC Biologics S.p.A.
Sanofi
Sanofi